From the Gal-1 and Gal-3 activation point of view, their expressions have been increased only by specific gene promoters in cancer settings [171,172,173] and, to our knowledge, no specific activators have been tested either in OP or different diseases. This evidence concerns the gene LGALS3 and cancer.